Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.

Caleb P Skipper,Katelyn A Pastick,Nicole Engen,Ananta S Bangdiwala,Mahsa Abassi,Sarah M Lofgren,Darlisha A. Williams,Elizabeth C Okafor,Matthew F Pullen,Melanie R. Nicol,Alanna A Nascene,Katherine Huppler Hullsiek,Matthew P. Cheng,Darlette Luke,Sylvain A. Lother,Lauren J. MacKenzie,Glen Drobot,Lauren E. Kelly,Ilan S. Schwartz,Ryan Zarychanski,Emily G. McDonald,Todd C. Lee,Radha Rajasingham,David R. Boulware

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial.

2020

There is no known effective oral therapy for early COVID-19. This randomized, double-blind, placebo-controlled trial evaluated effects of oral hydroxychloroquine on symptoms and disease severity in...

Keywords:

Internal medicine
MEDLINE
Hydroxychloroquine
oral therapy
Cardiology
Medicine
disease severity
Diabetes mellitus
Randomized controlled trial
2019 20 coronavirus outbreak
Coronavirus disease 2019

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

285

Citations